Integrated multi-omics analyses reveal Jorunnamycin A as a novel suppressor for muscle-invasive bladder cancer by targeting FASN and TOP1

BACKGROUND: Bladder cancer is a urological carcinoma with high incidence, among which muscle invasive bladder cancer (MIBC) is a malignant carcinoma with high mortality. There is an urgent need to develop new drugs with low toxicity and high efficiency for MIBC because existing medication has defect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ruijiao, Hao, Xiaopeng, Chen, Jingyuan, Zhang, Changyue, Fan, Huixia, Lian, Fuming, Chen, Xiaochuan, Wang, Chao, Xia, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428641/
https://www.ncbi.nlm.nih.gov/pubmed/37587470
http://dx.doi.org/10.1186/s12967-023-04400-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428641/
https://www.ncbi.nlm.nih.gov/pubmed/37587470
http://dx.doi.org/10.1186/s12967-023-04400-3

Ejemplares similares